| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/16/2009 | WO2009047770A3 Cytoplasmic malate dehydrogenase (mdh1) targeted treatment for neurodegenerative diseases |
| 07/16/2009 | WO2009046860A3 Use of dago as a therapeutic agent |
| 07/16/2009 | WO2009046859A3 Use of af12198 and dago as therapeutic agents |
| 07/16/2009 | WO2009046198A3 Sustained delivery of compstatin analogs from gels |
| 07/16/2009 | WO2009046015A3 Combination therapies for treating type 1 diabetes |
| 07/16/2009 | WO2009040778A3 Pharmaceutical compositions containing the enzyme cyprosin, an aspartic peptidase from cynara cardunculus and its inclusion in antitumour formulations |
| 07/16/2009 | WO2009040035A3 Use of a peptide as a therapeutic agent |
| 07/16/2009 | WO2009039990A3 Use of icam peptide as a therapeutic agent |
| 07/16/2009 | WO2009039974A3 Use of peptide asp-arg-gly-asp-ser-oh as a therapeutic agent |
| 07/16/2009 | WO2009037539A3 Treatment of oestrogen dependant conditions in pre-menopausal women |
| 07/16/2009 | WO2009033817A3 Use of the combination of the hcv-1 e2 protein (484-499) and the human pancreatic polypeptide as a therapeutic agent |
| 07/16/2009 | WO2009033121A3 Molecules and methods for treatment and detection of diabetes |
| 07/16/2009 | WO2009027561A3 Oral pharmaceutical desmopressin composition |
| 07/16/2009 | WO2009004315A8 Isolated peptides and uses thereof |
| 07/16/2009 | WO2008157747A8 Use of inhibition of exonuclease 1 in methods for therapy and diagnostic of neurodegenerative diseases, eye diseases, and mitochondrial disorders |
| 07/16/2009 | WO2008149354A3 Agents for the treatment of inflammatory diseases and methods of using same |
| 07/16/2009 | WO2008145855A8 Pharmaceutical and/or cosmetic composition containing a cytochrome c-activating active ingredient |
| 07/16/2009 | WO2008145854A8 Pharmaceutical and/or cosmetic composition containing peptides |
| 07/16/2009 | WO2008145852A8 Pharmaceutical and/or cosmetic composition containing an active ingredient which is antioxidant and which activates cell energy |
| 07/16/2009 | WO2008145851A8 Pharmaceutical and/or cosmetic composition containing peptides |
| 07/16/2009 | WO2008128169A8 Sparc and methods of use thereof |
| 07/16/2009 | WO2008125903A3 Method of inhibiting an undesired immune response |
| 07/16/2009 | WO2008125366A3 Treatment of autoimmune diseases |
| 07/16/2009 | WO2008114037A8 Treatment of inflammation and/or endotoxic shock |
| 07/16/2009 | WO2008110695A8 Novel multimeric molecules, method for preparing same and use thereof in the preparation of drugs |
| 07/16/2009 | WO2008090360A8 Methods |
| 07/16/2009 | WO2008062110A8 Cosmetic and/or pharmaceutical composition containing at least one peptide as the active ingredient and use of said peptide |
| 07/16/2009 | WO2008040111A8 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/16/2009 | WO2008015383A8 Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies |
| 07/16/2009 | WO2008012542A8 Polysaccharide derivatives of erythropoietin |
| 07/16/2009 | WO2008001045A8 Members of the glycoside hydrolase family 31 family of proteins |
| 07/16/2009 | WO2008000028A8 Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease |
| 07/16/2009 | WO2007139433A8 Peptide substance normalizing the metabolism in osseous and cartilaginous tissues, pharmaceutical composition on its base and the method of its application |
| 07/16/2009 | WO2007135390A8 Prevention of plaque formation |
| 07/16/2009 | WO2007113531A8 Topical drug delivery |
| 07/16/2009 | WO2007107654A8 Cyclopeptide with anti-cancer activity derived from collagen type iv |
| 07/16/2009 | WO2007098611A8 Compositions for treatment of cancer |
| 07/16/2009 | WO2003038054A3 Structure-based design and synthesis of fgf inhibitors and fgf modulator compounds |
| 07/16/2009 | WO2002086063A3 Xenobiotic compound modulated expression systems and uses therefor |
| 07/16/2009 | US20090183285 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
| 07/16/2009 | US20090183278 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
| 07/16/2009 | US20090183277 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
| 07/16/2009 | US20090183276 Novel Bacillus Thuringiensis Gene with Coleopteran Activity |
| 07/16/2009 | US20090183268 Methods and systems for medical sequencing analysis |
| 07/16/2009 | US20090183267 Mouse models carrying a knock-out mutation of the qpct-gene |
| 07/16/2009 | US20090182303 Targeted Therapeutic Agent Release for Weight Loss Therapy |
| 07/16/2009 | US20090182121 Regulation of Human Transmembrane Serine Protease |
| 07/16/2009 | US20090181927 Bonding tissues and cross-linking proteins with naphthalimide compounds |
| 07/16/2009 | US20090181907 Drug Comprising As The Active Ingredient Proliferative Vector Containing Survivin Promoter |
| 07/16/2009 | US20090181902 Modulators of pharmacokinetic properties of therapeutics |
| 07/16/2009 | US20090181901 Compositions and methods to increase bioavailability of carotenoids |
| 07/16/2009 | US20090181900 Novel peptides and methods for the treatment of inflammatory disease |
| 07/16/2009 | US20090181899 Low-molecular weight peptides inhibiting ion channel activity |
| 07/16/2009 | US20090181898 Abuse-resistant amphetamine prodrugs |
| 07/16/2009 | US20090181897 Cxcr4 antagonist and use thereof |
| 07/16/2009 | US20090181896 Use of Natriuretic Peptide Receptor Antagonists to Treat Ocular, Otic and Nasal Edemetous Conditions |
| 07/16/2009 | US20090181895 Stabilised Compositions of Factor VII Polypeptides |
| 07/16/2009 | US20090181894 Chimeric toxins for targeted therapy |
| 07/16/2009 | US20090181893 Use of agents that prevent generation of amyloid and amyloid-like lipoproteins, and/or use of agents that promote sequestration and/or degradation of, and/or prevent neurotoxicity of such proteins in the treatment of hearing loss and improving body balance |
| 07/16/2009 | US20090181892 Methods and kits for treating joints and soft tissues |
| 07/16/2009 | US20090181891 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers; used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 213P1F11 can be used in active or passive immunization. |
| 07/16/2009 | US20090181890 Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders |
| 07/16/2009 | US20090181889 Compositions and methods for detection and treatment of human herpesvirus (hhv)-6 |
| 07/16/2009 | US20090181888 Skin Repair Accelerating Therapeutic Agent Containing Ghrelin and Derivatives Thereof or Substance Acting On GHS-R1a as Active Ingredient |
| 07/16/2009 | US20090181887 Use of a glp-1 molecule for treatment of biliary dyskinesia and/or biliary pain/discomfort |
| 07/16/2009 | US20090181886 Method for Determining the Concentration of the Adipocytic Form of the Fatty Acid Binding Protein (A-FABP, FABP4, P2) |
| 07/16/2009 | US20090181885 Novel compounds and their effects on feeding behaviour |
| 07/16/2009 | US20090181884 Novel apolipoprotein gene involved in lipid metabolism |
| 07/16/2009 | US20090181883 HUMAN CHORIONIC GONADOTROPIN (hCG) FORMULATIONS FOR FACILITATING WEIGHT LOSS AND BODY CONTOURING |
| 07/16/2009 | US20090181882 Methods and preparations for curing critically ill patients |
| 07/16/2009 | US20090181881 Compositions and Methods for Suppression of Amyloid Plaque Formation Associated with Neurodegenerative Disorders |
| 07/16/2009 | US20090181880 Methods for treatment of headaches by administration of oxytocin |
| 07/16/2009 | US20090181879 Methods for Monitoring Neuroinflammatory Destruction of Neurons and for Treating Diseases Having an Inflammatory component related to phospholipase A2 |
| 07/16/2009 | US20090181102 Process for obtaining high efficiency human albumin for use in detoxification therapy |
| 07/16/2009 | US20090181100 Dry powder aerosols of Nanoparticulate drugs |
| 07/16/2009 | US20090181093 Methods for treating soft tissue damage associated with a surgical procedure |
| 07/16/2009 | US20090181081 Systemic Treatment of Pathological Conditions Resulting From Oxidative Stress and/or Redox Imbalance |
| 07/16/2009 | US20090181065 Methods and devices for promoting endothelial morphogenesis |
| 07/16/2009 | US20090181058 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 07/16/2009 | US20090181057 Methods and Compositions for the Inhibition of Thrombus Formation |
| 07/16/2009 | US20090181044 Novel Flavivirus antigens |
| 07/16/2009 | US20090181042 Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine |
| 07/16/2009 | US20090181035 Plexind1 agonists and their use |
| 07/16/2009 | US20090181032 facilitate drug delivery of other molecules; e.g. use intraocularly in eye surgery, glaucoma, retinopathy treatments |
| 07/16/2009 | US20090181028 B-cell epitope peptides of hsp 65, novel amino acid sequences, dna encoding the amino acid sequences of said peptides, antibodies directed against said peptides and different uses thereof in the treatment of inflammatory and autoimmune diseases |
| 07/16/2009 | US20090181026 Tomoregulin-2-antibody compositions and methods for the diagnosis and treatment of Alzheimer's disease |
| 07/16/2009 | US20090181024 Novel composition and methods for the treatment of immune related diseases |
| 07/16/2009 | US20090181017 Prevention and treatment of complement-associated eye conditions |
| 07/16/2009 | US20090181014 Compositions and methods for the diagnosis and treatment of tumor |
| 07/16/2009 | US20090181013 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 07/16/2009 | US20090181011 Compounds, Compositions and Methods for the Endocytic Presentation of Immunosuppressive Factors |
| 07/16/2009 | US20090181010 Arginase II: a target for the prevention of atherosclerosis |
| 07/16/2009 | US20090181008 Methods of treating alzheimer's disease |
| 07/16/2009 | US20090181007 Culture medium and pharmaceutical composition for regenerating cartilage tissue, a method, uses and products related thereto |
| 07/16/2009 | US20090181006 Methods for diagnosing and treating cerebrovascular events based on nr2 peptides |
| 07/16/2009 | US20090181005 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 07/16/2009 | US20090181004 Modified beta-lactamase and method for its preparation |
| 07/16/2009 | US20090181003 Regulation of S6 Kinsase Protein Activity and Related Methods |
| 07/16/2009 | US20090181002 Reduced coenzyme q10-containing composition which is stable against oxidation, and method for stabilization of reduced coenzyme q10 |
| 07/16/2009 | US20090180995 Novel anticoagulant polypeptides and complex |